LCE1A Inhibitors
LCE1A inhibitors consist of a variety of chemical compounds that, through different mechanisms, lead to the decreased functional activity of LCE1A, a protein involved in the differentiation of keratinocytes within the epidermis. For instance, both retinoic acid and tazarotene, members of the retinoid family, work by modulating the differentiation and proliferation of keratinocytes, resulting in the downregulation of LCE1A, which is typically upregulated during the later stages of epidermal differentiation. Similarly, vitamin D analogs such as calcipotriol and tacalcitol bind to the vitamin D receptor, thereby promoting keratinocyte differentiation and subsequently diminishing the expression of LCE1A. Hydroquinone, by affecting melanogenesis and keratinocyte function, indirectly influences Lthe expression of LCE1A, while methotrexate's inhibition of dihydrofolate reductase reduces keratinocyte proliferation, indirectly leading to a decrease in LCE1A activity.
Additionally, compounds like anthralin and salicylic acid exert their inhibitory effects on LCE1A by promoting keratinocyte differentiation and disrupting keratinocyte adhesion, respectively. Anthralin triggers differentiation, which can suppress LCE1A expression as part of a negative feedback mechanism. Salicylic acid, through its exfoliative action, affects the structural integrity of keratinocytes, which indirectly can lead to reduced LCE1A expression. Immune modulators such as imiquimod and pimecrolimus alter cytokine profiles and T-cell activation, respectively, impacting keratinocyte behavior and consequently leading to the diminished expression of LCE1A. Agents like 5-fluorouracil halt DNA synthesis and cell proliferation, which in turn results in reduced functional activity of LCE1A in epidermal differentiation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A (retinol), is known to modulate skin differentiation and proliferation. LCE1A expression is downregulated by retinoic acid, which promotes terminal differentiation of keratinocytes, thus leading to a decreased functional activity of LCE1A in the epidermis. | ||||||
Calcipotriol | 112965-21-6 | sc-203537 sc-203537A | 10 mg 50 mg | $203.00 $832.00 | 4 | |
Calcipotriol, a vitamin D analog, binds the vitamin D receptor, influencing keratinocyte differentiation. By promoting differentiation, calcipotriol diminishes the expression of LCE1A, which is associated with the late-differentiation stages of epidermal keratinocytes. | ||||||
Hydroquinone | 123-31-9 | sc-204773 sc-204773A sc-204773B | 250 g 1 kg 5 kg | $37.00 $93.00 $400.00 | ||
Hydroquinone inhibits melanogenesis. It leads to altered keratinocyte function and can have a secondary effect on the expression of differentiation-related proteins like LCE1A through changes in the keratinocyte's microenvironment. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, a dihydrofolate reductase inhibitor, can lead to reduced proliferation of keratinocytes. This decrease in proliferation can indirectly lead to decreased LCE1A expression since LCE1A is part of the epidermal differentiation complex. | ||||||
Tazarotene | 118292-40-3 | sc-220193 | 10 mg | $103.00 | ||
Tazarotene is a synthetic retinoid that modulates keratinocyte proliferation and differentiation. Its action leads to the normalization of keratinocyte growth, which can result in diminished expression of LCE1A, a protein involved in epidermal differentiation. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod, an immune response modifier, induces cytokine production which can affect keratinocyte differentiation. The altered immune response can lead to changes in the expression of proteins like LCE1A that are involved in the formation of the skin barrier. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil inhibits thymidylate synthase, reducing DNA synthesis and keratinocyte proliferation. With decreased proliferation, there is a consequent reduction in the expression of LCE1A, whose function is related to the differentiation of epidermal cells. | ||||||
Salicylic acid | 69-72-7 | sc-203374 sc-203374A sc-203374B | 100 g 500 g 1 kg | $47.00 $94.00 $119.00 | 3 | |
Salicylic acid, a beta hydroxy acid, promotes exfoliation and can alter keratinocyte adhesion. By disrupting keratinocyte function, salicylic acid indirectly influences the expression of differentiation proteins such as LCE1A. | ||||||
Pimecrolimus | 137071-32-0 | sc-208172 | 1 mg | $140.00 | 2 | |
Pimecrolimus can modify T-cell activation which indirectly affects keratinocyte function and differentiation. This modulation can lead to decreased expression of LCE1A, a protein involved in epidermal differentiation and barrier formation. | ||||||